Stat5 Promotes Survival of Mammary Epithelial Cells through Transcriptional Activation of a Distinct Promoter in Akt1

被引:66
作者
Creamer, Bradley A.
Sakamoto, Kazuhito
Schmidt, Jeffrey W.
Triplett, Aleata A.
Moriggl, Richard [3 ]
Wagner, Kay-Uwe [1 ,2 ]
机构
[1] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, DRCII, Omaha, NE 68198 USA
[2] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68198 USA
[3] Ludwig Boltzmann Inst Canc Res, A-1090 Vienna, Austria
基金
奥地利科学基金会;
关键词
NUCLEAR FACTOR-I; TRANSGENIC MICE; GLAND INVOLUTION; SIGNAL TRANSDUCER; GLUCOCORTICOID-RECEPTOR; CONDITIONAL KNOCKOUT; SECRETORY EPITHELIUM; FORCED ACTIVATION; BREAST CANCERS; BINDING-SITES;
D O I
10.1128/MCB.00851-09
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The signal transducer and activator of transcription 5 (Stat5) plays a pivotal role in the proliferation, secretory differentiation, and survival of mammary epithelial cells. However, there is little information about Stat5 target genes that facilitate these biological processes. We provide here experimental evidence that the prolactin-mediated phosphorylation of Stat5 regulates the transcriptional activation of the Akt1 gene. Stat5 binds to consensus sequences within the Akt1 locus in a growth factor-dependent manner to initiate transcription of a unique Akt1 mRNA from a distinct promoter, which is only active in the mammary gland. Elevating the levels of active Akt1 restores the expression of cyclin D1 and proliferation of Jak2-deficient mammary epithelial cells, which provides evidence that Akt1 acts downstream of Jak/Stat signaling. The ligand-inducible expression of Stat5 in transgenic females mediates a sustained upregulation of Akt1 in mammary epithelial cells during the onset of postlactational involution. Stat5-expressing mammary glands exhibit a delay in involution despite induction of proapoptotic signaling events. Collectively, the results of the present study elucidate an underlying mechanism by which active Stat5 mediates evasion from apoptosis and self-sufficiency in growth signals.
引用
收藏
页码:2957 / 2970
页数:14
相关论文
共 54 条
[1]   A road map for those who don't know JAK-STAT [J].
Aaronson, DS ;
Horvath, CM .
SCIENCE, 2002, 296 (5573) :1653-1655
[2]   Stat3-induced apoptosis requires a molecular switch in PI(3)K subunit composition [J].
Abell, K ;
Bilancio, A ;
Clarkson, RWE ;
Tiffen, PG ;
Altaparmakov, AI ;
Burdon, TG ;
Asano, T ;
Vanhaesebroeck, B ;
Watson, CJ .
NATURE CELL BIOLOGY, 2005, 7 (04) :392-398
[3]   The Jak/Stat pathway - A novel way to regulate PI3K activity [J].
Abell, K ;
Watson, CJ .
CELL CYCLE, 2005, 4 (07) :897-900
[4]   Delayed mammary gland involution in MMTV-AKT1 transgenic mice [J].
Ackler, S ;
Ahmad, S ;
Tobias, C ;
Johnson, MD ;
Glazer, RI .
ONCOGENE, 2002, 21 (02) :198-206
[5]   Prolactin and transforming growth factor-β signaling exert opposing effects on mammary gland morphogenesis, involution, and the Akt-forkhead pathway [J].
Bailey, JP ;
Nieport, KM ;
Herbst, MP ;
Srivastava, S ;
Serra, RA ;
Horseman, ND .
MOLECULAR ENDOCRINOLOGY, 2004, 18 (05) :1171-1184
[6]  
BELLACOSA A, 1993, ONCOGENE, V8, P745
[7]   Suppression of Neu-induced mammary tumor growth in cyclin D1 deficient mice is compensated for by cyclin E [J].
Bowe D.B. ;
Kenney N.J. ;
Adereth Y. ;
Maroulakou I.G. .
Oncogene, 2002, 21 (2) :291-298
[8]   Lsoform-specific requirement for Akt1 in the developmental regulation of cellular metabolism during lactation [J].
Boxer, Robert B. ;
Stairs, Douglas B. ;
Dugan, Katherine D. ;
Notarfrancesco, Kathleen L. ;
Portocarrero, Carla P. ;
Keister, Blaine A. ;
Belka, George K. ;
Cho, Han ;
Rathmell, Jeffrey C. ;
Thompson, Craig B. ;
Birnbaum, Morris J. ;
Chodosh, Lewis A. .
CELL METABOLISM, 2006, 4 (06) :475-490
[9]   IGF-2 is a mediator of prolactin-induced morphogenesis in the breast [J].
Brisken, C ;
Ayyannan, A ;
Nguyen, C ;
Heineman, A .
DEVELOPMENTAL CELL, 2002, 3 (06) :877-887
[10]   PRL activates the cyclin D1 promoter via the Jak2/Stat pathway [J].
Brockman, JL ;
Schroeder, MD ;
Schuler, LA .
MOLECULAR ENDOCRINOLOGY, 2002, 16 (04) :774-784